You just read:

ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis

News provided by

ALS Therapy Development Foundation

Jan 27, 2010, 08:00 ET